Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

A retrospective analysis of HIV-associated Kaposi's sarcoma in patients with non-detectable HIV viral loads and CD4+ counts greater than 300 cells/μL

D Mani and D Aboulafia

Infectious Agents and Cancer 2009 4(Suppl 2):P1

Published on: 17 June 2009

Development and application of a real time PCR assay for detection and quantification of merkel cell virus (MCV) in archived formalin fixed paraffin embedded tissue samples of merkel cell carcinoma and other cancers

R Modali, J Goedert, E Engels, LW Ayers and K Bhatia

Infectious Agents and Cancer 2009 4(Suppl 2):O1

Published on: 17 June 2009

AIDS-associated plasmablastic lymphoma presenting as a poorly differentiated esophageal tumor: a diagnostic dilemma

D Mani, D Guinee Jr and D Aboulafia

Infectious Agents and Cancer 2009 4(Suppl 2):P2

Published on: 17 June 2009

Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

J Bohlius

Infectious Agents and Cancer 2009 4(Suppl 2):O2

Published on: 17 June 2009

Four year survival in untreated AIDS related-Kaposi sarcoma (AIDS-KS) in Jos, Nigeria

P Agaba, E Anya, Z Hassan, L Apena, O Agbaji, M Mua'Zu, B Badung and J Idoko

Infectious Agents and Cancer 2009 4(Suppl 2):P3

Published on: 17 June 2009

Immunodeficiency, HIV RNA plasma viral load and risk of AIDS-defining and non-AIDS-defining neoplasia, ANRS CO3 Aquitaine Cohort (1998–2006)

M Bruyand, R Thiebaut, F Dabis, S Lawson-Ayayi, P Joly, AJ Sasco, P Mercie, JL Pellegrin, S Geffard, D Neau, P Morlat, G Chene and F Bonnet

Infectious Agents and Cancer 2009 4(Suppl 2):O3

Published on: 17 June 2009

Malignancies in HIV infected children at a tertiary cancer hospital in India

A Alahari Dhir, S Sawant, G Bharia and S Banavali

Infectious Agents and Cancer 2009 4(Suppl 2):P4

Published on: 17 June 2009

A population-based study of how children are exposed to saliva in Africa: implications for KSHV transmission

LM Butler, S Mzolo, A Mosam and JN Martin

Infectious Agents and Cancer 2009 4(Suppl 2):O4

Published on: 17 June 2009

Suppression of galectin-3 in KSHV infected DMVEC cells and Kaposi's sarcoma: implications for tumorigenesis

DJ Alcendor, WQ Zhu, P Desai and GS Hayward

Infectious Agents and Cancer 2009 4(Suppl 2):P5

Published on: 17 June 2009

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy

HQ Nguyen, F Okuku, F Ssewankambo, AS Magaret, C Johnston, A Wald, A Kambugu, L Corey, J Orem and C Casper

Infectious Agents and Cancer 2009 4(Suppl 2):O5

Published on: 17 June 2009

Value of CD44 immunostaining (IHC) as a surrogate in the differentiation of MYC-positive Burkitt lymphoma (BL) and Burkitt lymphoma-like (BLL) from MYC-negative Diffuse Large B-Cell Lymphoma (DLBCL) in a resource constrained clinical setting

LW Ayers, M Ogwang, W Zhou, SM Mbulaiteye and K Bhatia

Infectious Agents and Cancer 2009 4(Suppl 2):P6

Published on: 17 June 2009

Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma

GM Clifford, M Rickenbach and S Franceschi

Infectious Agents and Cancer 2009 4(Suppl 2):O6

Published on: 17 June 2009

Evaluation of Epstein-Barr virus (EBV) and human herpes virus-8 (HHV-8) in HIV-associated persistent generalized lymphadenopathy (PGL)

LW Ayers, G Dominguez and K Bhatia

Infectious Agents and Cancer 2009 4(Suppl 2):P7

Published on: 17 June 2009

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers

A Bhatt, P Bhende and B Damania

Infectious Agents and Cancer 2009 4(Suppl 2):O7

Published on: 17 June 2009

Therapeutic options in AIDS related Kaposi's sarcoma: a 5-year Nigerian review

AA Babadoko, MS Shehu, SM Aminu and AM Suleiman

Infectious Agents and Cancer 2009 4(Suppl 2):P8

Published on: 17 June 2009

High resolution profiling of DNA copy number and gene expression changes in AIDS-related lymphoma

KE Deffenbacher, Z Liu, J Iqbal, H Geng, K Fu and WC Chan

Infectious Agents and Cancer 2009 4(Suppl 2):O8

Published on: 17 June 2009

Dendritic cell-mediated infection of primary B cells with KSHV

R Bagni, E Barsov, B Ortiz-Conde, D Dittmer, V Kewalramani, D Ott, C Sadowski, P Tuma, F Ruscetti and D Whitby

Infectious Agents and Cancer 2009 4(Suppl 2):P9

Published on: 17 June 2009

Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab

K Dunleavy, RF Little, AS Wayne, N Grant, S Pittaluga, ES Jaffe, S Steinberg, R Yarchoan, J Carrasquillo, J Janik and WH Wilson

Infectious Agents and Cancer 2009 4(Suppl 2):O9

Published on: 17 June 2009

Survival and prognosis of HIV-associated non-Hodgkin-lymophma in the era of combined anti-retroviral therapy, a European multi-cohort study

J Bohlius

Infectious Agents and Cancer 2009 4(Suppl 2):P10

Published on: 17 June 2009

Epidemiology of non-keratinocytic skin cancers among persons with AIDS in the United States

E Lanoy, GM Dores, MM Madeleine, JR Toro, JF Fraumeni and EA Engels

Infectious Agents and Cancer 2009 4(Suppl 2):O10

Published on: 17 June 2009